John M Maris

Title: Innovations and Contributions of John M Maris

Introduction

John M Maris is a prominent inventor based in Philadelphia, PA, known for his significant contributions to the field of immunotherapy. With a total of five patents to his name, Maris has made strides in cancer treatment through innovative methods and compositions.

Latest Patents

One of his latest patents is titled "Methods and compositions for use of tumor self-antigens in adoptive immunotherapy." This patent provides methods and compositions for immunotherapy that employ modified T cells or NK cells. These cells comprise receptors that bind to newly identified tumor antigens, which can be administered to patients for the treatment of diseases such as cancer. Additionally, he has developed polynucleotides and vectors encoding these tumor antigens. Another notable patent is "Glypican 2 as a cancer marker and therapeutic target." This patent focuses on antibodies that bind to Glypican 2 and outlines methods for using these antibodies to treat cancers that express or overexpress the Glypican 2 antigen.

Career Highlights

Throughout his career, John M Maris has worked with esteemed organizations such as The Children's Hospital of Philadelphia and the National Institutes of Health, a component of the US Department of Health & Human Services. His work in these institutions has allowed him to advance research in cancer therapies and contribute to the scientific community.

Collaborations

Maris has collaborated with notable colleagues, including Dimiter Stanchev Dimitrov and Zhongyu Zhu. These collaborations have further enriched his research and development efforts in the field of immunotherapy.

Conclusion

John M Maris stands out as an influential inventor in the realm of cancer treatment, with a focus on innovative immunotherapy methods. His patents and career achievements reflect his dedication to advancing medical science and improving patient outcomes.